124 related articles for article (PubMed ID: 3530350)
21. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation.
Sariban E; Mitchell T; Griffin J; Kufe DW
J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
23. Proto-oncogene expression in a human chondrosarcoma cell line: HCS-2/8.
Zhu JD; Pan HO; Suzuki F; Takigawa M
Jpn J Cancer Res; 1994 Apr; 85(4):364-71. PubMed ID: 8200849
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Vedantham S; Gamliel H; Golomb HM
Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
[TBL] [Abstract][Full Text] [Related]
25. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
[TBL] [Abstract][Full Text] [Related]
26. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
[TBL] [Abstract][Full Text] [Related]
28. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.
Drexler HG; Janssen JW; Brenner MK; Hoffbrand AV; Bartram CR
Blood; 1989 May; 73(6):1656-63. PubMed ID: 2496772
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of action of interferon-alpha (IFN-alpha) in hairy-cell leukaemia; Hu-IFN-alpha 2 receptor expression by hairy cells and other normal and leukaemic cell types.
Dadmarz R; Evans T; Secher D; Marshall N; Cawley J
Leuk Res; 1986; 10(11):1279-85. PubMed ID: 2948077
[TBL] [Abstract][Full Text] [Related]
30. Expression of the IFN alpha receptor in hairy cell leukaemia.
Platanias LC; Pfeffer LM; Barton KP; Vardiman JW; Golomb HM; Colamonici OR
Br J Haematol; 1992 Nov; 82(3):541-6. PubMed ID: 1486034
[TBL] [Abstract][Full Text] [Related]
31. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
32. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
[TBL] [Abstract][Full Text] [Related]
33. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
35. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
[TBL] [Abstract][Full Text] [Related]
36. Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon).
Worman CP; Nethersell AB; Bottomley JM; Apostolov K; Barker W; Cawley JC
Klin Wochenschr; 1987 Jul; 65(14):685-7. PubMed ID: 3306138
[TBL] [Abstract][Full Text] [Related]
37. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
Yaar M; Peacocke M; Cohen MS; Gilchrest BA
J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
[TBL] [Abstract][Full Text] [Related]
38. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
[TBL] [Abstract][Full Text] [Related]
39. Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.
Lauria F; Zinzani PL; Raspadori D; Foà R; Buzzi M; Gugliotta L; Bocchia M; Benfenati D; Tura S
Eur J Haematol Suppl; 1990; 52():3-6. PubMed ID: 2279543
[TBL] [Abstract][Full Text] [Related]
40. Expression of major histocompatibility class I genes in differentiating leukemic cells is temporally related to activation of c-fos proto-oncogene.
Barzilay J; Kushtai G; Plaksin D; Feldman M; Eisenbach L
Leukemia; 1987 Mar; 1(3):198-204. PubMed ID: 3312838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
